-
Alibaba founder Jack Ma and TENCENT (00700.HK)  -3.900 (-3.145%)    Short selling $112.23M; Ratio 6.332%   Chairman Ma Hua Teng will participate in the fund raising plan of PING AN (02318.HK)  +0.550 (+0.846%)    Short selling $1.36B; Ratio 26.811%   though the H-shares, reported China Securities Journal.

Comments

Post a Comment

Popular posts from this blog

-
UCD (01599) plans to raise Rmb600m from A shares issue    Beijing Urban Construction Design & Development Group (UCD) (01599) said it proposes to apply for initial public offering of Renminbi ordinary shares and listing.   The number of public issuance of shares amounts to not more than 149.86 million shares. The issuance price of A shares shall not be lower than Rmb2.91 per share.   The total proceeds raised from the issuance of A shares amount to Rmb600 million, which will be used for upgrading and reconstructing project of the design centre, the national  engineering...
Read more
-
HSBC lifts Li Ning (02331) to HK$9.1 HSBC Global Research lifted its target price for Li Ning (02331) to HK$9.1 from HK$7.7, and reiterated its "buy" rating as it remains confident about continued market share and margin recovery.   The research house sees room for the shares to re-rate further in 2018 on the back of improving SSSG, stronger future orders, and potential dividend.   HSBC raised its earnings forecast by 5%-9% for FY2018/19 driven by 2-5% higher revenue  and improved operating leverage. It forecast sales to reach RMB10.2bn, above its  historical peak of RM...
Read more
-
PRADA Deutsche Bank believed and hoped PRADA (01913.HK)    -0.150 (-0.312%)    Short selling $12.87M; Ratio 35.577%   's performance had reached bottom in the third quarter. Looking ahead for the fourth quarter, with the Asian business getting back to normal, relatively low base in the second half of the year and the launch of new products, the company's sales growth may accelerate. Given the expected negative trend of the company's revenue, coupled with deleveraging, the company's EPS forecasts for FY2014-2015 were further cut by 7% and 5% respectively. The Hold rating was maintained and target price was reduced from $55 to $54. 
Read more